REFI vs REGN · P/E 7.8, rev $13.7M vs P/E 14, rev $14.34B
Chicago Atlantic Real Estate Finance Inc (REFI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Chicago Atlantic Real Estate Finance Inc (REFI) is a reit - mortgage company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported REFI revenue for 2023-06-30 was $13.7M. Net income was $8.6M. Revenue was down 8.3% from 2023-03-31 to 2023-06-30. REFI currently screens at market cap $237.1M and trailing P/E 7.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
REFI currently screens at market cap $237.1M and trailing P/E 7.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the REFI and REGN stock pages for the full models.
Not investment advice.